Why is Thyrocare Tech. falling/rising?

As of 28-Jul, Thyrocare Technologies Ltd is experiencing a decline in its stock price, currently at Rs 1,242.30, which reflects a decrease of Rs 70.7 or 5.38%. The stock has underperformed its sector by 4.43% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 7.17%. Despite touching an intraday high of Rs 1,348.95, the stock also reached a low of Rs 1,234.70. Over the past week, Thyrocare has shown a positive return of 4.91%, and over the last month, it has increased by 24.64%. However, the stock's recent performance is overshadowed by a significant drop in investor participation, with delivery volume falling by 52.06% compared to the five-day average. While the company boasts strong financial metrics, including a high return on equity and consistent profit growth, it faces challenges such as a high valuation and 100% of promoter shares being pledged, which may contribute to the recent price decline.
In the broader market context, Thyrocare's short-term performance contrasts with the benchmark Sensex, which has declined by 1.59% over the past week. While Thyrocare has outperformed the Sensex in the long term, generating a return of 60.07% over the past year compared to the Sensex's decline of 0.54%, the current market conditions and the stock's recent underperformance may be influencing investor sentiment negatively. The combination of high valuations, pledged shares, and declining trading volumes suggests that despite the company's strong fundamentals, external market pressures and internal risks are contributing to the stock's current downward trajectory.